Vaccine against human papillomvirus effective against recurrence of infection.
As reported in the NY Times, a new study has found that vaccine against human papillomavirus (HPV) can reduce the incidence of recurrence of virus related diseases. The effect was found to be significant even among women who have undergone surgery for cervical cancer caused by HPV. The study has been published in the journal, BMJ.
The lead author, Dr. Elmar A. Joura, and team investigated a group of 1,350 women in the age group of 15 – 26 years and who had undergone cervical surgery. 587 of them had been administered the HPV vaccine and 763 had placebo shot. Following up for a period of 2 years showed that women who received vaccine were 465 less likely to suffer from HPV related disease. Women who had serious types of cancer were 64% less likely to contract a HPV infection when compared to those who were administered a placebo.
Thus, vaccine seemed to be effective in preventing recurrence as well and it would be better to get vaccinated regardless of age, or medical history to prevent disease.
Related posts:
- Secret anti-aging gene also prevents diabetes and cancer
- Prostate Cancer And Sexual Function: Study Sheds Light On Prediction
- Study By Dr. Armando Giuliano Suggests that Lymph Node Biopsy, Removal Doesnt Alter Breast Cancer Survival Rates
- Breast cancer Survivor Andrea Mitchell’s Fight and 1-in-8 Statistic Controversy
- The Path to the HPV Vaccine was Paved with Nuns, Rabbits, Cows and Prostitutes